Abbonarsi

Accuracy of the GeneXpert® MRSA/SA SSTI test to diagnose methicillin-resistant Staphylococcus spp. infection in bone fixation and fusion and management of infected non-unions - 22/09/24

Doi : 10.1016/j.otsr.2024.103820 
Théo Martin a, b, c, , Pierre Martinot d, Jean-Thomas Leclerc a, b, c, e, Marie Titécat b, c, f, Caroline Loïez b, c, f, Julien Dartus a, b, c, Alain Duhamel b, g, Henri Migaud a, b, c, Christophe Chantelot b, c, h, Barthélémy Lafon Desmurs b, c, j, Thomas Amouyel a, b, c, Eric Senneville b, c, j
a Service d’orthopédie, hôpital Salengro, CHU de Lille, place de Verdun, 59000, Lille, France 
b CHU de Lille, Hôpital Salengro, University of Lille, Hauts-de-France, 59000, Lille, France 
c Centre de référence des infections ostéo-articulaires complexes Nord-Ouest (CRIOAC-NO), hôpital Salengro, CHU de Lille, place de Verdun, 59000, Lille, France 
d Département de chirurgie orthopédique, groupement des hôpitaux de l’institut catholique de Lille, université catholique de Lille, Lomme, France 
e Département de chirurgie orthopédique, CHU de Québec-université Laval, Quebec, Canada 
f Microbiologie, centre de biologie pathologie Pierre-Marie Degand, CHU de Lille, boulevard du Pr Jules-Leclercq, 59000 Lille, France 
g Centre d’étude et de recherche en informatique médicale, maison de la recherche clinique hospitalière et universitaire, CHU de Lille, 6, rue du Professeur-Laguesse, 59000 Lille, France 
h Service de traumatologie, hôpital Salengro, CHU de Lille, place de Verdun, 59000 Lille, France 
j Service universitaire des maladies infectieuses, CH de Dron, 155, rue du Président-Coty, 59200 Tourcoing, France 

Corresponding author. Service d’orthopédie II, hôpital Salengro, CHU de Lille, place de Verdun, 59000 Lille, France.Service d’orthopédie II, hôpital Salengro, CHU de Lilleplace de VerdunLille59000France

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Introduction

The GeneXpert® MRSA/SA SSTI (Methicillin Resistant Staphylococcus aureus/S. aureus skin and soft tissue infection) PCR test allows early detection of methicillin resistance in staphylococci. This test was developed for skin infections and has been evaluated for prosthetic joint infections but, to our knowledge, has not been evaluated for hardware infections outside of arthroplasties. Furthermore, we conducted a retrospective study in patients with non-prosthetic osteosynthesis hardware aiming: (1) to identify the diagnostic values of the PCR test compared to conventional cultures and the resulting rate of appropriate antibiotic therapy; (2) to identify the rate of false negative (FN) results; (3) to identify and compare the rates of failure of infectious treatment (FN versus others); (4) to search for risk factors for FN of the PCR test.

Hypothesis

The PCR test allowed early and appropriate targeting of antibiotic therapy.

Material and methods

The results of PCR tests and conventional cultures for osteoarticular infections of non-prosthetic hardware over four years (2012–2016) were compared to identify the diagnostic values of using the results of conventional culture as a reference and the rate of appropriate antibiotic therapies. Infectious management failures between the results of the FN group and the others were compared, and variables associated with a FN of the PCR test were identified.

Results

The analysis of 419 PCR tests allowed us to establish a sensitivity of 42.86%, a specificity of 96.82%, a positive predictive value of 60% and a negative predictive value of 93.83%. Using the results of the PCR test for the targeting of postoperative antibiotic therapy, it was suitable for staphylococcal coverage in 90.94% (381/419). The rates of patients for whom infectious treatment failed were not significantly different between the FN group and the other patients (20.8% versus 17.7%, respectively; Hazard Ratio=1.12 (95%CI 0.47-2.69, p=0.79)). A skin opening during the initial trauma (p=0.005) and a polymicrobial infection were significantly associated with a risk of FN from the PCR test (p<0.001).

Conclusion

The PCR test makes it possible to reduce the duration of empirical broad-spectrum antibiotic therapy during the treatment of an infection of osteosynthesis hardware but causes a lack of antibiotic coverage in 9.06% of cases.

Level of evidence

III; diagnostic case control study.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Hardware infection, Prosthetic joint infection, Staphylococcus spp., Methicillin resistance, Infected non-union


Mappa


© 2024  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 110 - N° 6

Articolo 103820- ottobre 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • Bone consolidation under septic condition and hardware retention: about 69 patients
  • Alizé Dabert, Adrien Runtz, Grégoire Leclerc, Pauline Sergent, François Loisel, Isabelle Pluvy, Thomas Fradin, Patrick Garbuio
| Articolo seguente Articolo seguente
  • Benefit-risks analysis of thoracoplasty in adolescent idiopathic scoliosis treated by sublaminar bands
  • Cédric Duray, Brice Ilharreborde, Marc Khalifé, Florence Julien-Marsollier, Anne-Laure Simon, Emmanuelle Ferrero

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.